233 related articles for article (PubMed ID: 10809722)
21. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
Park HI; Turk BE; Gerkema FE; Cantley LC; Sang QX
J Biol Chem; 2002 Sep; 277(38):35168-75. PubMed ID: 12119297
[TBL] [Abstract][Full Text] [Related]
22. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
23. Cloning, expression, purification, and characterization of rat MMP-12.
Fu JY; Lyga A; Shi H; Blue ML; Dixon B; Chen D
Protein Expr Purif; 2001 Mar; 21(2):268-74. PubMed ID: 11237688
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
Shimada T; Nakamura H; Ohuchi E; Fujii Y; Murakami Y; Sato H; Seiki M; Okada Y
Eur J Biochem; 1999 Jun; 262(3):907-14. PubMed ID: 10411655
[TBL] [Abstract][Full Text] [Related]
25. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
26. A smallest 6 kda metalloprotease, mini-matrilysin, in living world: a revolutionary conserved zinc-dependent proteolytic domain- helix-loop-helix catalytic zinc binding domain (ZBD).
Yu WH; Huang PT; Lou KL; Yu SS; Lin C
J Biomed Sci; 2012 May; 19(1):54. PubMed ID: 22642296
[TBL] [Abstract][Full Text] [Related]
27. A conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone.
Pavlaki M; Cao J; Hymowitz M; Chen WT; Bahou W; Zucker S
J Biol Chem; 2002 Jan; 277(4):2740-9. PubMed ID: 11704671
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
29. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
Marchenko GN; Ratnikov BI; Rozanov DV; Godzik A; Deryugina EI; Strongin AY
Biochem J; 2001 Jun; 356(Pt 3):705-18. PubMed ID: 11389678
[TBL] [Abstract][Full Text] [Related]
30. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
Uría JA; López-Otín C
Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
[TBL] [Abstract][Full Text] [Related]
31. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
[TBL] [Abstract][Full Text] [Related]
32. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
[TBL] [Abstract][Full Text] [Related]
33. Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development.
Llano E; Pendás AM; Aza-Blanc P; Kornberg TB; López-Otín C
J Biol Chem; 2000 Nov; 275(46):35978-85. PubMed ID: 10964925
[TBL] [Abstract][Full Text] [Related]
34. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
[TBL] [Abstract][Full Text] [Related]
36. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
37. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions.
Wingfield PT; Sax JK; Stahl SJ; Kaufman J; Palmer I; Chung V; Corcoran ML; Kleiner DE; Stetler-Stevenson WG
J Biol Chem; 1999 Jul; 274(30):21362-8. PubMed ID: 10409697
[TBL] [Abstract][Full Text] [Related]
38. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
English WR; Puente XS; Freije JM; Knauper V; Amour A; Merryweather A; Lopez-Otin C; Murphy G
J Biol Chem; 2000 May; 275(19):14046-55. PubMed ID: 10799478
[TBL] [Abstract][Full Text] [Related]
39. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
40. Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin).
Bejarano PA; Noelken ME; Suzuki K; Hudson BG; Nagase H
Biochem J; 1988 Dec; 256(2):413-9. PubMed ID: 3223920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
